Salmeterol xinafoateProduct ingredient for Salmeterol

Name
Salmeterol xinafoate
Drug Entry
Salmeterol

Salmeterol is a long-acting beta-2 adrenergic receptor agonist drug that is currently prescribed for the treatment of asthma and chronic obstructive pulmonary disease COPD.8,9,10,11,12 It has a longer duration of action than the short-acting beta-2 adrenergic receptor agonist, salbutamol.5 Salmeterol was first described in the literature in 1988.6 Salmeterol's structure is similar to salbutamol's with an aralkyloxy-alkyl substitution on the amine.1

Salmeterol was granted FDA approval on 4 February 1994.7

Accession Number
DBSALT001372
Structure
Synonyms
salmeterol 1-hydroxy-2-naphthoate
External IDs
GR 33343 G / GR-33343 G / GR-33343X
UNII
6EW8Q962A5
CAS Number
94749-08-3
Weight
Average: 603.756
Monoisotopic: 603.319602793
Chemical Formula
C36H45NO7
InChI Key
XTZNCVSCVHTPAI-UHFFFAOYSA-N
InChI
InChI=1S/C25H37NO4.C11H8O3/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21;12-10-8-4-2-1-3-7(8)5-6-9(10)11(13)14/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2;1-6,12H,(H,13,14)
IUPAC Name
1-hydroxynaphthalene-2-carboxylic acid; 4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)-2-(hydroxymethyl)phenol
SMILES
OC(=O)C1=C(O)C2=CC=CC=C2C=C1.OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC1=CC=CC=C1
ChemSpider
51216
ChEBI
9012
ChEMBL
CHEMBL1082607
Wikipedia
Salmeterol
Predicted Properties
PropertyValueSource
Water Solubility0.00226 mg/mLALOGPS
logP3.82ALOGPS
logP3.61Chemaxon
logS-5.3ALOGPS
pKa (Strongest Acidic)10.12Chemaxon
pKa (Strongest Basic)9.4Chemaxon
Physiological Charge1Chemaxon
Hydrogen Acceptor Count5Chemaxon
Hydrogen Donor Count4Chemaxon
Polar Surface Area81.95 Å2Chemaxon
Rotatable Bond Count17Chemaxon
Refractivity122.39 m3·mol-1Chemaxon
Polarizability49.49 Å3Chemaxon
Number of Rings4Chemaxon
Bioavailability0Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleYesChemaxon